ADHD
Study links childhood ADHD traits to higher odds of physical illness and disability by midlife
Ti AI ṣe iroyin Àwòrán tí AI ṣe Ti ṣayẹwo fun ododo
A decades-long UK cohort study following 10,930 people born in 1970 found that children who showed more attention-deficit/hyperactivity disorder (ADHD) traits at age 10 had higher odds of multiple self-reported physical health conditions and physical health–related disability by age 46. The research, published in JAMA Network Open, suggests smoking, psychological distress and higher body mass index partly help explain the link, and highlights the need for better identification and support across adulthood.
Researchers have identified brain connectivity patterns tied to autism symptom severity in children diagnosed with either autism or ADHD. The findings, from a study led by the Child Mind Institute, suggest shared biological mechanisms across these conditions regardless of formal diagnosis. These patterns align with genetic activity involved in neural development.
Ti AI ṣe iroyin
Collegium Pharmaceutical, Inc. (COLL) held an investor conference call on March 19, 2026, to discuss its acquisition of AZSTARYS and relevant corporate subsidiaries from Corium Therapeutics. The deal aims to expand the company's position in the ADHD market. Executives including CEO Vikram Karnani joined the call.
Attention deficit hyperactivity disorder (ADHD) affects nearly 6% of school-aged youth in France. With early intervention, it does not hinder a child's success. Psychoeducation is crucial for proper diagnosis and support.